New patent for Global Blood drug OXBRYTA

Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are six patents protecting this drug. This drug…

The post New patent for Global Blood drug OXBRYTA appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!